Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset
ISIS-VIRUS
1 other identifier
observational
2,000
1 country
1
Brief Summary
The purpose of this study is to investigate viral factors determining the early onset of T1D. Thanks to the quantification of viral exposures of T1D patients before the disease onset with questionnaires and environmental databases analyses, and through whole genome association studies of these patients, investigators could attempt to identify gene-virus interactions determining the age of T1D onset.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 7, 2014
CompletedFirst Posted
Study publicly available on registry
April 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedJune 28, 2016
June 1, 2016
7.8 years
August 7, 2014
June 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Occurrence of viral events before T1D diagnosis
From birth to 2 years
Delay between viral events and T1D diagnosis
From birth to 2 years
Secondary Outcomes (1)
Age at T1D diagnosis as a quantitative trait
From birth to 2 years
Study Arms (1)
Isis-Virus
T1D patients of the Isis-Diab cohort with genetic data (GWAS) and specific environmental data on viral events during childhood
Interventions
Questionnaires on viral events during mother's pregnancy and patient's childhood, health book copies, addresses' geolocation, quantification of viral exposures using Sentinel Network data
Collect of blood samples for DNA extraction and genetic characterization (GWAS) on Illumina platform (Centre National de Genotypage)
Eligibility Criteria
patients of the Isis-Diab cohort, i.e. T1D patients aged more than 6 months, already sampled for genetic analysis.
You may qualify if:
- Type 1 diabetic patients included in the Isis-Diab cohort
- Patients with available genetic data (GWAS)
You may not qualify if:
- Patient refusal (or parents) to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inserm U986
Le Kremlin-Bicêtre, 94276, France
Biospecimen
whole blood (already collected for the Isis-Diab project)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alain-Jacques Valleron, PhD
Institut National de la Santé Et de la Recherche Médicale, France
- STUDY DIRECTOR
Pierre Bougnères, MD, PhD
Inserm U986 / Pediatric endocrinology department of the Bicêtre Hospital (AP-HP)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2014
First Posted
April 24, 2015
Study Start
March 1, 2010
Primary Completion
December 1, 2017
Study Completion
June 1, 2018
Last Updated
June 28, 2016
Record last verified: 2016-06